Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues

EU orphan designation number: EU/3/16/1637   
Active ingredient: Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues
Indication: Treatment of primary hyperoxaluria
Sponsor: Alnylam Netherlands B.V.
Strawinskylaan 3051, 1077 ZX, Amsterdam, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/03/2016 Orphan designation EMA/OD/195/15 (2016)1875 of 21/03/2016
11/10/2017 Change of name and/or address of sponsor
25/02/2019 Transfer of orphan designation EMA/OD/0000003680 (2019)1633 of 21/02/2019